Cardiovascular Risk Factors and Atherogenic Indices in an Iranian Population: Birjand East of Iran

Toba Kazemi, Morteza Hajihosseini, Maryam Moossavi, Mina Hemmati, Masood Ziaee, Toba Kazemi, Morteza Hajihosseini, Maryam Moossavi, Mina Hemmati, Masood Ziaee

Abstract

Introduction: The alteration in serum lipid profile; increase in total cholesterol (TC), triacylglycerol (TAG), and low-density lipoprotein cholesterol (LDL-C); and reduction in high-density lipoprotein cholesterol (HDL-C) are key factors in cardiovascular disease progression. The high prevalence and severity of cardiovascular diseases require new screening tools for better evaluation. Atherogenic index (AI) (LDL-C/HDL-C) and coronary risk index (CRI) (TC/HDL-C) can be strong markers for predicting the risk of atherosclerosis and coronary heart disease and disclose the presence of LDL or TAG in the serum of related patients. To implement this strategy, the AIs and CRIs in our population were assessed. In this study, a total of 5207 subjects were recruited and AIs and CRIs were calculated for all of them. According to our data, age, body mass index, sex, as well as CRI and AI had affirmative correlation with TC, LDL-C, TAG, systolic blood pressure, and diastolic blood pressure. By increasing these factors, AIs and CRIs were augmented. Moreover, in situations where all atherogenic parameters are normal, these parameters may be the alternative screening tool.

Keywords: Atherogenic index; cardiovascular disease; coronary risk index; lipid profile.

Conflict of interest statement

Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Comparison of BMI, lipid profile, and atherogenic indices related to sex. AI indicates atherogenic index; BMI, body mass index; CRI, coronary risk index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride.
Figure 2.
Figure 2.
Correlation between lipid profile and atherogenic indices. AI indicates atherogenic index; CRI, coronary risk index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride. ***Statistically significant at α = .001

References

    1. Kazemi T, Sharifzadeh GR, Zarban A, et al. Risk factors for premature myocardial infarction: a matched case-control study. J Res Health Sci. 2011;11:77–82.
    1. Kazemi T, Sharifzadeh G, Zarban A, Fesharakinia A. Comparison of components of metabolic syndrome in premature myocardial infarction in an Iranian population: a case control study. Int J Prev Med. 2013;4:110–114.
    1. Dehghani Firoozabadi M, Kazemi T, Sharifzadeh G, Dadbeh S, Dehghan P. Stroke in Birjand, Iran: a hospital-based study of acute stroke. Iran Red Crescent Med J. 2013;15:264–268.
    1. Landray M, Sagar G, Muskin J, Murray S, Holder R, Lip G. Association of atherogenic low-density lipoprotein subfractions with carotid atherosclerosis. Quar J Med. 1998;91:345–351.
    1. Carmena R, Duriez P, Fruchart JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 2004;109:III-2-III-7.
    1. Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation. 1992;85:37–45.
    1. Ebrahimzadeh A, Azarkar Z, Ziaee M, Sharifzadeh G, Bijari B. Prevalence and risk factors of hepatitis c infection (HCV) in Birjand, Iran, 2014. Int J Infect. 2016;3:e34102.
    1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421.
    1. Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis. 2009;19:401–408.
    1. Conkbayir C, Burak A, Ökçün EB. Lipid variables related to the extent and severity of coronary artery disease in non-diabetic Turkish Cypriots. Iran J Public Health. 2015;44:1196.
    1. Barzi F1, Patel A, Woodward M, et al. ; Collaboration APCS. A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region. Ann Epidemiol. 2005;15:405–413.
    1. Gaziano JM, Hennekens CH, O’Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997;96:2520–2525.
    1. Bampi ABA, Rochitte CE, Favarato D, Lemos PA, Da Luz PL. Comparison of non-invasive methods for the detection of coronary atherosclerosis. Clinics (Sao Paulo). 2009;64:675–682.
    1. Kearns K, Dee A, Fitzgerald AP, Doherty E, Perry IJ. Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level. BMC Public Health. 2014;14:1.
    1. Jiang Y, Chen Y, Manuel D, Morrison H, Mao Y. Quantifying the impact of obesity category on major chronic diseases in Canada. Sci World J. 2007;7:1211–1221.
    1. Onat A, Can G, Kaya H, Hergenç G. Atherogenic index of plasma (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol. 2010;4:89–98.
    1. Kanthe PS, Patil BS, Bagali S, Deshpande A, Shaikh GB, Aithala M. Atherogenic index as a predictor of cardiovascular risk among women with different grades of obesity. Int J Collab Res Int Med Public Health. 2012;4:1767–1774.
    1. Nansseu JRN, Moor VJA, Nouaga MED, Zing-Awona B, Tchanana G, Ketcha A. Atherogenic index of plasma and risk of cardiovascular disease among Cameroonian postmenopausal women. Lipids Health Dis. 2016;15:49.
    1. Nwagha UI, Igwe J. Atherogenic index of plasma: a significant indicator for the onset of atherosclerosis during menopause in hypertensive females of South East Nigeria. J College Med. 2006;10:67–71.
    1. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213–219.
    1. Bittner V, Johnson BD, Zineh I, et al. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the women’s ischemia syndrome evaluation (WISE). Am Heart J. 2009;157:548–555.
    1. Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, et al. Atherogenic index of plasma (AIP): a marker of cardiovascular disease. Med J Islamic Republic Iran. 2015;29:240.
    1. Khazaál MS. Atherogenic index of plasma (AIP) as a parameter in predicting cardiovascular risk in males compared to the conventional dyslipidemic indices (cholesterol ratios). Karbala J Med. 2013;6:1506–1511.
    1. Njajou OT, Kanaya AM, Holvoet P, et al. Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the health, aging and body composition study. Diabetes Metab Res Rev. 2009;25:733–739.
    1. Daniels L, Laughlin G, Sarno M. Lp-PLA2 is an independent predictor of incident coronary heart disease in appparently healthy older population. J Am Col Cardiol. 2008;51:913–919.
    1. Dobiásová M, Urbanová Z, Samánek M. Relations between particle size of HDL and LDL lipoproteins and cholesterol esterification rate. Physiol Res. 2005;54:159–165.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera